Receptor tyrosine kinases expressed in metastatic colon cancer - PubMed (original) (raw)
. 1995 Mar 16;60(6):791-7.
doi: 10.1002/ijc.2910600611.
Affiliations
- PMID: 7896447
- DOI: 10.1002/ijc.2910600611
Receptor tyrosine kinases expressed in metastatic colon cancer
R J Craven et al. Int J Cancer. 1995.
Abstract
Using a PCR-based cloning technique, we have isolated a series of DNA fragments coding for tyrosine kinases that are expressed in a metastatic human colon tumor, and have subsequently analyzed their expression pattern at the protein level in human tumors. We identified both the alpha and the beta forms of the platelet-derived growth factor receptor (PDGFR), axl and 8 other genes, including 3 cytoplasmic tyrosine kinases. To study their expression in human colon cancer, we performed Western blots of matched sets of normal tissues and of carcinomas from the same patient. These revealed that the alpha-PDGFR migrates predominantly as a 200-kDa band in 8/8 normal tissues, and as a 170-kDa band in 17/17 malignant tissues, as well as in colonic polyps, suggesting that expression of an isoform of this receptor may be a marker for the progression of colon cancer. Additional studies showed that the Axl receptor tyrosine kinase was expressed at 10-fold higher levels in a peritoneal metastatic nodule than in other normal and malignant tissues. Immunohistochemistry revealed Axl over-expression specifically in the malignant cells of the tumor. This indicates that over-expression and possibly a differential processing event of tyrosine kinase receptors may be involved in colon cancer, and that they are potential markers for the progression of this disease.
Similar articles
- Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.
Chen WS, Kung HJ, Yang WK, Lin Wc. Chen WS, et al. Int J Cancer. 1999 Nov 26;83(5):579-84. doi: 10.1002/(sici)1097-0215(19991126)83:5<579::aid-ijc1>3.0.co;2-r. Int J Cancer. 1999. PMID: 10521789 - PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
Brunschwig EB, Wilson K, Mack D, Dawson D, Lawrence E, Willson JK, Lu S, Nosrati A, Rerko RM, Swinler S, Beard L, Lutterbaugh JD, Willis J, Platzer P, Markowitz S. Brunschwig EB, et al. Cancer Res. 2003 Apr 1;63(7):1568-75. Cancer Res. 2003. PMID: 12670906 - Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis.
Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke RP, Levin M, Urieli-Shoval S. Gutfeld O, et al. J Histochem Cytochem. 2006 Jan;54(1):63-73. doi: 10.1369/jhc.5A6645.2005. Epub 2005 Aug 22. J Histochem Cytochem. 2006. PMID: 16116035 - Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
Dibb NJ, Dilworth SM, Mol CD. Dibb NJ, et al. Nat Rev Cancer. 2004 Sep;4(9):718-27. doi: 10.1038/nrc1434. Nat Rev Cancer. 2004. PMID: 15343278 Review. - [Prognostic biomarkers for metastatic colorectal cancer].
Neumann JH. Neumann JH. Pathologe. 2016 Nov;37(Suppl 2):180-185. doi: 10.1007/s00292-016-0204-6. Pathologe. 2016. PMID: 27638531 Review. German.
Cited by
- The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.
Meyer AS, Miller MA, Gertler FB, Lauffenburger DA. Meyer AS, et al. Sci Signal. 2013 Aug 6;6(287):ra66. doi: 10.1126/scisignal.2004155. Sci Signal. 2013. PMID: 23921085 Free PMC article. - Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer.
Yan D, Earp HS, DeRyckere D, Graham DK. Yan D, et al. Cancers (Basel). 2021 Nov 11;13(22):5639. doi: 10.3390/cancers13225639. Cancers (Basel). 2021. PMID: 34830794 Free PMC article. Review. - Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases.
Sanachai K, Mahalapbutr P, Choowongkomon K, Poo-Arporn RP, Wolschann P, Rungrotmongkol T. Sanachai K, et al. ACS Omega. 2020 Jan 2;5(1):369-377. doi: 10.1021/acsomega.9b02800. eCollection 2020 Jan 14. ACS Omega. 2020. PMID: 31956784 Free PMC article. - Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.
Rothlin CV, Leighton JA, Ghosh S. Rothlin CV, et al. Inflamm Bowel Dis. 2014 Aug;20(8):1472-80. doi: 10.1097/MIB.0000000000000050. Inflamm Bowel Dis. 2014. PMID: 24846720 Free PMC article. Review. - The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
Uribe DJ, Mandell EK, Watson A, Martinez JD, Leighton JA, Ghosh S, Rothlin CV. Uribe DJ, et al. PLoS One. 2017 Jul 20;12(7):e0179979. doi: 10.1371/journal.pone.0179979. eCollection 2017. PLoS One. 2017. PMID: 28727830 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous